Inhibiting effect of astragalus polysaccharides on the functions of CD4 +CD25 hightreg cells in the tumor microenvironment of human hepatocellular carcinoma

Chinese Medical Journal

Volumn 125, Issue 5, 2012, Pages 786-793

  Li, Qiang ^a,b   Bao, Jian Min ^b   Li, Xiao Li ^c   Zhang, Ti ^a   Shen, Xiao Hong ^d  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN UNIVERSITY   (China)

^c TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^d NANKAI UNIVERSITY   (China)

Author keywords

Astragalus polysaccharides; Hepatocellular carcinoma; Regulatory T cells; Tumor microenvironment

Indexed keywords

ASTRAGALUS POLYSACCHARIDES; CD4 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 7 RECEPTOR; MESSENGER RNA; PLANT EXTRACT; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASTRAGALUS MEMBRANACEUS; CANCER STAGING; CD4+ CD25+ T LYMPHOCYTE; CELL MIGRATION; CELL POPULATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; LIVER CELL CARCINOMA; LIVER RESECTION; MALE; PHENOTYPE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; TUMOR MICROENVIRONMENT;

ASTRAGALUS PLANT; CARCINOMA, HEPATOCELLULAR; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LIVER NEOPLASMS; POLYSACCHARIDES; T-LYMPHOCYTES, REGULATORY;

EID: 84863357066     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2012.05.012     Document Type: Article

References (27)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156.
2. Hao XS, Wang PP, Chen KX, Li Q, He M, Yu SB, et al. Twenty-year trends of primary liver cancer incidence rate in an urban Chinese population. Eur J Can Prev 2003; 12: 273-279.
3. Takayama T, Sekine T, Makuuchi M, Yamasaki S, Kosuge T, Yamamoto J, et al. Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial. Lancet 2000; 11: 356: 784-785.
4. Maloy KJ, Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol 2001; 2: 816-822.
5. O'Garra A, Vieira P. Regulatory T cells and mechanisms of immunesystem control. Nat Med 2004; 10: 801-805.
6. Curiel TJ, Coukos G, Zou L, Alvarez X, Cheng P, Mottram P, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 2004; 10: 942-949.
7. Kondělková K, Vokurková D, Krejsek J, Borská L, Fiala Z, Ctirad A. Regulatory T cells (TREG) and their roles in immune system with respect to immunopathological disorders. Acta Medica (Hradec Kralove) 2010; 53: 73-77.
8. high T cells are enriched in the tumor and peripheral blood of prostate cancer patients J Immunol 2006; 177: 7398-7405.
9. Ormandy LA, Hillemann T, Wedemeyer H, Manns MP, Greten TF, Korangy F. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res 2005; 65: 2457-2464.
10. + regulatory T cells. Nat Rev Drug Discov 2009; 8: 969-981.
11. +CD127-low regulatory T cell in NOD mouse. Immunological J 2010; 4: 316-317.
12. Chen W, Li YM, Yu MH. Astragalus polysaccharides: an effective treatment for diabetes revention in NOD mice. Exp Clin Endocrinol Diabetes 2008; 116: 468-474.
13. Li RJ, Qiu SD, Chen HX, Tian H, Wang XH. The Immunoth erapeutic effects of Astragalus polysaccharide in type 1 diabetic mice. Biol Pharm Bull 2007; 30: 470-476.
14. Li RJ, Qiu SD, Chen HX, Wang LR. Immunomodulatory effects of Astragalus polysaccharide in diabetic mice. Chin J Integr Med (Chin) 2008; 6: 166-170.
15. Shao P, Zhao LH, Zhi-Chen, Pan JP. Regulation on maturation and function of dendritic cells by Astragalus mongholicus polysaccharides. Int Immunopharmacol 2006; 6: 1161-1166.
16. + T-cell pool and the expression of Foxp3 in vivo. Int Immunol 2004; 16: 1241-1249.
17. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003; 299: 1057-1061.
18. + regulatory T cells. Nat Immunol 2003; 4: 330-336.
19. Fontenot J, Rasmussen J, Williams L, Dooley J, Farr A, Rudensky A. Regulatory T cell line age specification by the forkhead transcription factor foxp3. Immunity 2005; 22: 329-341.
20. + T cells: multiple pathways on the road. J Cell Physiol 2007; 211: 590-597.
21. Suri-Payer E, Fritzsching B. Regulatory T cells in experimental autoimmune disease. Springer Semin Immunopathol 2006; 28: 3-16.
22. + regulatory T cells. Carcinoma Lab Invest 2007; 87: 582-590.
23. + T cells as a functionally and phenotypically distinct immunoregulatory T cell subpopulation. Int Immunol 2000; 12: 1145-1155.
24. + regulatory T cells. J Exp Med 2005; 4: 201: 1061-1067.
25. + T cell subsets. J Leukoc Biol 2007; 82: 335-346.
26. Liu H, Pan Z, Li A, Fu S, Lei Y, Sun H, et al. Roles of chemokine receptor 4 (CXCR4) and chemokine.ligand (CXCL12) in metastasis of hepatocellular carcinoma cells. Cell Mol Immunol 2008; 5: 373-378.
27. + regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res 2004; 64: 8451-8455.